Please assess the completion status of the following clinical trial:

Trial Title: HFNC Effect on BCSS in Patients With COPD

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~One previous chronic obstructive pulmonary disease exacerbation in last year.~Exclusion Criteria:~Can not be oxygen dependant PaCO2 \< 60

- Gender: ALL
- Minimum Age: 35 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- High Flow Nasal Cannula Participants (Type: EXPERIMENTAL): High Flow Nasal Cannula Participants will be their own control, they will be in study for 3 months prior to receiving equipment and then will be studied for 3 additional months on study.

Based on this trial design, predict the completion outcome and termination type (if applicable).